100 years of insulin: how the discovery of the hormone revolutionized the treatment of type 1 diabetes
DOI:
https://doi.org/10.33448/rsd-v10i15.22757Keywords:
Type 1 diabetes; Insulin; Therapy of type 1 diabetes.Abstract
The year of 2021 was a milestone for medicine and especially for patients diagnosed with diabetes, as it completed 100 years of the discovery of exogenous insulin. This medicine has completely revolutionized thousands of people's quality of life, as well as providing healthcare and the pharmaceutical industry a new perspective. In this context, it is important to show that type 1 diabetes mellitus is an autoimmune disease, meaning that the body itself attacks insulin-producing cells, called beta cells, therefore, it is essential that these patients use this hormone exogenously throughout their entire life's period. Currently, there are several types of insulin and technologies in constant development that aim to facilitate adherence and promote greater well-being for these people. Considering that the present literary review aims to describe the main types of diabetes, possible causes, existing treatments, consequences of lack of glucose control, the discovery of insulin, technologies and a brief comparison between the United States' and the Brazilian healthcare system. Using bibliographic materials as a research source, this article is a descriptive article about type 1 diabetes, which, considering the estimates and current prevalence, makes the discussion about this disease indispensable.
References
(k) Premarket Notification. (2021). Food & Drug Administration (FDA). Acesso em 15 de novembro de 2021 às 17:46. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?start_search=1&productcode=LZG&knumber=&applicant=INSULET%20CORPORATION
A.F.P. (2020). Insulina, vital para diabéticos, tem mercado ilegal e gratuito nos EUA. EXAME. https://exame.com/ciencia/insulina-vital-para-diabeticos-tem-mercado-negro-e-gratuito-nos-eua/
Advani A. (2020). Positioning time in range in diabetes management. Diabetologia, 63(2), 242–252. https://doi.org/10.1007/s00125-019-05027-0
Ahmad K. (2014). Insulin sources and types: a review of insulin in terms of its mode on diabetes mellitus. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 34(2), 234–237. https://doi.org/10.1016/s0254-6272(14)60084-4
Almeida de Sousa, A., Caetano Albernaz, A., & da Rocha Sobrinho, H. M. (2016). Diabetes Melito tipo 1 autoimune: aspectos imunológicos.
Alsaleh, F. M., Smith, F. J., Keady, S., & Taylor, K. M. (2010). Insulin pumps: from inception to the present and toward the future. Journal of clinical pharmacy and therapeutics, 35(2), 127–138. https://doi.org/10.1111/j.1365-2710.2009.01048.x
American Diabetes Association (2012). Diagnosis and classification of diabetes mellitus. Diabetes care, 35 Suppl 1(Suppl 1), S64–S71. https://doi.org/10.2337/dc12-s064
Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., & Deckert, T. (1983). Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia, 25(6), 496–501. https://doi.org/10.1007/BF00284458
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. Lancet (London, England), 383(9911), 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7
Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R., & Fletcher, A. A. (1922). Pancreatic Extracts in the Treatment of Diabetes Mellitus. Canadian Medical Association journal, 12(3), 141–146.
Banting, F. G., Sir, 1891-1941. (1920). Note dated Oct 31/20 from loose leaf notebook 1920/21. insulin: N10002. https://insulin.library.utoronto.ca/islandora/object/insulin%3AN10002
Banting, F. G., Sir, 1891-1941. (1922). Photograph of Banting with dog ca. https://insulin.library.utoronto.ca/islandora/object/insulin:S10001
Blair, J. C., McKay, A., Ridyard, C., Thornborough, K., Bedson, E., Peak, M., Didi, M., Annan, F., Gregory, J. W., Hughes, D. A., Gamble, C., & SCIPI investigators (2019). Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. BMJ (Clinical research ed.), 365, l1226. https://doi.org/10.1136/bmj.l1226
Boulton, A. J., Gries, F. A., & Jervell, J. A. (1998). Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic medicine: a journal of the British Diabetic Association, 15(6), 508–514. https://doi.org/10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L
Brasil. Lei Nº 8.080, De 19 De Setembro De 1990. http://www.planalto.gov.br/ccivil_03/leis/l8080.htm
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019). Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes & metabolism journal, 43(4), 383–397. https://doi.org/10.4093/dmj.2019.0121
Chan, J., & Cheng-Lai, A. (2017). Inhaled Insulin: A Clinical and Historical Review. Cardiology in review, 25(3), 140–146. https://doi.org/10.1097/CRD.0000000000000143
de M Bandeira, S., da Fonseca, L. J., da S Guedes, G., Rabelo, L. A., Goulart, M. O., & Vasconcelos, S. M. (2013). Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. International journal of molecular sciences, 14(2), 3265–3284. https://doi.org/10.3390/ijms14023265
Diabetes: pesquisa avalia os fatores associados à qualidade de vida. (2019). Fundação Oswaldo Cruz. Acesso em: 22 de setembro de 2021. https://portal.fiocruz.br/noticia/diabetes-pesquisa-avalia-os-fatores-associados-qualidade-de-vida
Diretrizes Sociedade Brasileira de Diabetes. (2019). Saúde Bahia. Acesso em: 15 de novembro de 2021. http://www.saude.ba.gov.br/wp-content/uploads/2020/02/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-2020.pdf
Gil, A. C. (2022). Como elaborar projetos de pesquisa. Atlas.
Hegele, R. A., & Maltman, G. M. (2020). Insulin's centenary: the birth of an idea. The lancet. Diabetes & endocrinology, 8(12), 971–977. https://doi.org/10.1016/S2213-8587(20)30337-5
Insulin Basics. (n.d.). American Diabetes Association. Acesso em 2 de novembro de 2021. https://www.diabetes.org/healthy-living/medication-treatments/insulin-other-injectables/insulin-basics
International Diabetes Federation. (2019). IDF Diabetes Atlas, 9th ed. https://www.diabetesatlas.org
International Working Group On The Diabetic Foot (IWGDF). (n.d) International Consensus on the Diabetic Foot and Practical Guidelines. Acesso em: 15 de outubro de 2021. http://iwgdf.org/consensus
Kim, E. S., & Plosker, G. L. (2015). AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus. Drugs, 75(14), 1679–1686. https://doi.org/10.1007/s40265-015-0472-0
Klafke, A., Duncan, B. B., Rosa, R. S., Moura, L., Malta, D. C., & Schmidt, M. I. (2014). Mortalidade por complicações agudas do diabetes melito no Brasil, 2006-2010. Epidemiologia e Serviços de Saúde. 23(3), 455-462. https://doi.org/10.5123/S1679-49742014000300008
Kravarusic, J., & Aleppo, G. (2020). Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes. Endocrinology and metabolism clinics of North America, 49(1), 37–55. https://doi.org/10.1016/j.ecl.2019.10.006
Malik, F. S., & Taplin, C. E. (2014). Insulin therapy in children and adolescents with type 1 diabetes. Paediatric drugs, 16(2), 141–150. https://doi.org/10.1007/s40272-014-0064-6
Marques, R. d. M. B., Fornés, N. S., & Stringhini, M. L. F. (2011). Fatores socioeconômicos, demográficos, nutricionais e de atividade física no controle glicêmico de adolescentes portadores de diabetes melito tipo 1. Arquivos Brasileiros de Endocrinologia & Metabologia, 55(3), 194–202. https://doi.org/10.1590/s0004-27302011000300004
Molitch, M. E., DeFronzo, R. A., Franz, M. J., Keane, W. F., Mogensen, C. E., Parving, H. H., Steffes, M. W., & American Diabetes Association (2004). Nephropathy in diabetes. Diabetes care, 27(1), S79–S83. https://doi.org/10.2337/diacare.27.2007.s79
Nascimento, O. J. M. d., Pupe, C. C. B., & Cavalcanti, E. B. U. (2016). Diabetic neuropathy. Revista Dor, 17. https://doi.org/10.5935/1806-0013.20160047
Nimri, R., Nir, J., & Phillip, M. (2020). Insulin Pump Therapy. American journal of therapeutics, 27(1), e30–e41. https://doi.org/10.1097/MJT.0000000000001097
Números do Diabetes no Brasil. (2021). Sociedade Brasileira de Endocrinologia e Metabologia. Acesso em 15 de novembro de 2021. https://www.endocrino.org.br/numeros-do-diabetes-no-brasil/
O que é insulina e tipos de insulina. (2021). BD. Acesso em: 13 de outubro de 2021. https://www.bd.com/pt-br/our-products/diabetes-care/diabetes-learning-center/insulin-treatment/what-is-insulin-and-insulin-types
Owens D. R. (2011). Insulin preparations with prolonged effect. Diabetes technology & therapeutics, 13 Suppl 1, S5–S14. https://doi.org/10.1089/dia.2011.0068
Premarket Approval (PMA). (2021). Food & Drug Administration (FDA). Acesso em 17 de novembro de 2021. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P160017
Premarket Approval (PMA). (2021). Food & Drug Administration (FDA). Acesso em 10 de novembro de 2021. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P140015S020
Pronin, T. (2019). Custo faz jovens racionarem insulina nos EUA; por que remédio lá é caro? Fonte: UOL: https://www.uol.com.br/vivabem/noticias/redacao/2019/09/27/custo-faz-jovens-racionarem-insulina-nos-eua-por-que-remedio-e-tao-caro.htm
Retnakaran, R., & Zinman, B. (2021). The ongoing evolution of basal insulin therapy over 100 years and its promise for the future. Diabetes, obesity & metabolism, 10.1111/dom.14552. Advance online publication. https://doi.org/10.1111/dom.14552
Ross, L. J., & Neville, K. A. (2019). Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes. Journal of paediatrics and child health, 55(6), 718–722. https://doi.org/10.1111/jpc.14480
Saleem, F., & Sharma, A. (2021). NPH Insulin. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549860/
Scheiner Gary, MS, CDE. (2020). Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin. Hachette Go; 3ª edição.
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014). Advanced glycation end products and diabetic complications. The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 18(1), 1–14. https://doi.org/10.4196/kjpp.2014.18.1.1
Site do Accu-chek. (s.d.). Accu-chek. Acesso em: 19 de outubro de 2021. https://www.accu-chek.com.br/br/ids/combo/
Tarr, J. M., Kaul, K., Wolanska, K., Kohner, E. M., & Chibber, R. (2012). Retinopathy in diabetes. In Advances in experimental medicine and biology (pp. 88–106). Springer New York. https://doi.org/10.1007/978-1-4614-5441-0_10
Tibaldi J. M. (2014). Evolution of insulin: from human to analog. The American journal of medicine, 127(10 Suppl), S25–S38. https://doi.org/10.1016/j.amjmed.2014.07.005
Umpierrez, G. E., & Klonoff, D. C. (2018). Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes care, 41(8), 1579–1589. https://doi.org/10.2337/dci18-0002
van Belle, T. L., Coppieters, K. T., & von Herrath, M. G. (2011). Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiological reviews, 91(1), 79–118. https://doi.org/10.1152/physrev.00003.2010
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International journal of medical sciences, 11(11), 1185–1200. https://doi.org/10.7150/ijms.10001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Luiza Lunardi de Freitas; Camila Robbi Semeghin; Bruna Kelly Sousa Hirata
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
